Recombinant erythropoietin therapy in renal and nonrenal anemia.
AUTOR(ES)
Erslev, A J
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1011260Documentos Relacionados
- Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.
- Erythropoietin therapy in patients with chronic renal failure.
- Cellular bioenergetics after erythropoietin therapy in chronic renal failure.
- 'Yewdow'-induced anemia.
- Lymphocyte dysfunction in congenital hypoplastic anemia.